Debiopharm Revenue
Pharmaceutical Manufacturing • 
Lausanne, Vaud, Switzerland • 201-500 Employees
Debiopharm revenue & valuation
| Annual revenue | $43,400,000 |
| Revenue per employee | $91,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $138,600,000 |
| Total funding | $2,100,000 |
Key Contacts at Debiopharm
Company overview
| Headquarters | Chemin Messidor 5-7, Lausanne, 1006, CH |
| Phone number | +41213210111 |
| Website | |
| NAICS | 3254 |
| SIC | 807 |
| Keywords | Healthcare, Oncology, Biopharmaceutical, Drug Delivery, Drug Development, Digital Health, Antimicrobials, Antibody Drug Conjugates, Science And Innovation, Radioligand Therapy, Dna Damage Response Inhibition |
| Founded | 1979 |
| Employees | 201-500 |
| Socials |
Debiopharm Email Formats
Debiopharm uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@debiopharm.com), used 50.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@debiopharm.com | 50.6% |
{first initial}.{last name} | j.doe@debiopharm.com | 44.7% |
{first initial}{last name} | jdoe@debiopharm.com | 3.1% |
About Debiopharm
Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical development and then select large pharmaceutical commercialization partners for out-licensing to maximize patient access across the globe. Through this specialized business model, Debiopharm can focus on the development of prescription drugs that target unmet medical needs in oncology and bacterial infections. Debiopharm completed the development and has licensed out 2 compounds: - Triptorelin, the active substance of Decapeptyl®/Trelstar®/Pamorelin®/Triptodur® 1, 3 and 6-month formulation and Moapar®/Salcacyl® -Oxaliplatin, the active substance of the branded Eloxatin®/Elplat®/Dacotin®/Dacplat® If your university or biotech start-up has interesting molecules in early-stage research and you’re seeking a competent and committed partner to develop them further, please contact us!
Employees by Management Level
Total employees: 201-500
Seniority
Employees
Employees by Department
Debiopharm has 252 employees across 16 departments.
Departments
Number of employees
Debiopharm Tech Stack
Discover the technologies and tools that power Debiopharm's digital infrastructure, from frameworks to analytics platforms.
Security
Marketing automation
JavaScript libraries
CDN
Web servers
Marketing automation
SEO
JavaScript libraries
Webmail
Programming languages
Blogs
Thailand
United Arab Emirates
Germany
Ireland
United States
Argentina
Canada
South AfricaFrequently asked questions
4.8
40,000 users
